BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30468210)

  • 1. Phenyl-γ-valerolactones and phenylvaleric acids, the main colonic metabolites of flavan-3-ols: synthesis, analysis, bioavailability, and bioactivity.
    Mena P; Bresciani L; Brindani N; Ludwig IA; Pereira-Caro G; Angelino D; Llorach R; Calani L; Brighenti F; Clifford MN; Gill CIR; Crozier A; Curti C; Del Rio D
    Nat Prod Rep; 2019 May; 36(5):714-752. PubMed ID: 30468210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Faecal Fermentation of Monomeric and Oligomeric Flavan-3-ols: Catabolic Pathways and Stoichiometry.
    Di Pede G; Bresciani L; Brighenti F; Clifford MN; Crozier A; Del Rio D; Mena P
    Mol Nutr Food Res; 2022 Nov; 66(21):e2101090. PubMed ID: 35107868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic and analytical strategies for the quantification of phenyl-γ-valerolactone conjugated metabolites in human urine.
    Brindani N; Mena P; Calani L; Benzie I; Choi SW; Brighenti F; Zanardi F; Curti C; Del Rio D
    Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28440064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the bioavailability of flavan-3-ols in humans: A systematic review and comprehensive data analysis.
    Di Pede G; Mena P; Bresciani L; Achour M; Lamuela-Raventós RM; Estruch R; Landberg R; Kulling SE; Wishart D; Rodriguez-Mateos A; Crozier A; Manach C; Del Rio D
    Mol Aspects Med; 2023 Feb; 89():101146. PubMed ID: 36207170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-individual variability in the production of flavan-3-ol colonic metabolites: preliminary elucidation of urinary metabotypes.
    Mena P; Ludwig IA; Tomatis VB; Acharjee A; Calani L; Rosi A; Brighenti F; Ray S; Griffin JL; Bluck LJ; Del Rio D
    Eur J Nutr; 2019 Jun; 58(4):1529-1543. PubMed ID: 29616322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Urinary Phenyl-γ-Valerolactones as Biomarkers of Dietary Flavan-3-ol Exposure.
    Parmenter BH; Shinde S; Croft K; Murray K; Bondonno CP; Genoni A; Christophersen CT; Bindon K; Kay C; Mena P; Del Rio D; Hodgson JM; Bondonno NP
    J Nutr; 2023 Aug; 153(8):2193-2204. PubMed ID: 37394116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites.
    Monagas M; Urpi-Sarda M; Sánchez-Patán F; Llorach R; Garrido I; Gómez-Cordovés C; Andres-Lacueva C; Bartolomé B
    Food Funct; 2010 Dec; 1(3):233-53. PubMed ID: 21776473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-(Hydroxyphenyl)-γ-Valerolactone-Sulfate, a Key Microbial Metabolite of Flavan-3-ols, Is Able to Reach the Brain: Evidence from Different in
    Angelino D; Carregosa D; Domenech-Coca C; Savi M; Figueira I; Brindani N; Jang S; Lakshman S; Molokin A; Urban JF; Davis CD; Brito MA; Kim KS; Brighenti F; Curti C; Bladé C; Del Bas JM; Stilli D; Solano-Aguilar GI; Santos CND; Del Rio D; Mena P
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31694297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic profile and urinary excretion of phenyl-γ-valerolactones upon consumption of cranberry: a dose-response relationship.
    Favari C; Mena P; Curti C; Istas G; Heiss C; Del Rio D; Rodriguez-Mateos A
    Food Funct; 2020 May; 11(5):3975-3985. PubMed ID: 32396592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabotypes of flavan-3-ol colonic metabolites after cranberry intake: elucidation and statistical approaches.
    Mena P; Favari C; Acharjee A; Chernbumroong S; Bresciani L; Curti C; Brighenti F; Heiss C; Rodriguez-Mateos A; Del Rio D
    Eur J Nutr; 2022 Apr; 61(3):1299-1317. PubMed ID: 34750642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoid-Derived Human Phenyl-γ-Valerolactone Metabolites Selectively Detoxify Amyloid-β Oligomers and Prevent Memory Impairment in a Mouse Model of Alzheimer's Disease.
    Ruotolo R; Minato I; La Vitola P; Artioli L; Curti C; Franceschi V; Brindani N; Amidani D; Colombo L; Salmona M; Forloni G; Donofrio G; Balducci C; Del Rio D; Ottonello S
    Mol Nutr Food Res; 2020 Mar; 64(5):e1900890. PubMed ID: 31914208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of Urinary Phenyl-γ-Valerolactones and Related Valeric Acids in Human Urine on Consumption of Apples.
    Anesi A; Mena P; Bub A; Ulaszewska M; Del Rio D; Kulling SE; Mattivi F
    Metabolites; 2019 Oct; 9(11):. PubMed ID: 31671768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of dietary flavan-3-ol intakes with plasma phenyl-γ-valerolactones: analysis from the TUDA cohort of healthy older adults.
    Angelino D; Caffrey A; McNulty H; Gill CI; Mena P; Rosi A; Moore K; Hoey L; Clements M; Laird E; Boyd K; Mullen B; Pucci B; Jarrett H; Cunningham C; Ward M; Strain JJ; McCarroll K; Moore AJ; Molloy AM; Del Rio D
    Am J Clin Nutr; 2023 Aug; 118(2):476-484. PubMed ID: 37307990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the Gut Microbiota's Ability to Metabolize Oligomeric and Polymeric Flavan-3-ols from Aronia and Cranberry.
    Lessard-Lord J; Roussel C; Guay V; Desjardins Y
    Mol Nutr Food Res; 2024 Mar; 68(5):e2300641. PubMed ID: 38350729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial Metabolites of Flavan-3-Ols and Their Biological Activity.
    Márquez Campos E; Stehle P; Simon MC
    Nutrients; 2019 Sep; 11(10):. PubMed ID: 31546992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability and catabolism of green tea flavan-3-ols in humans.
    Del Rio D; Calani L; Cordero C; Salvatore S; Pellegrini N; Brighenti F
    Nutrition; 2010; 26(11-12):1110-6. PubMed ID: 20080030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humans.
    Roowi S; Stalmach A; Mullen W; Lean ME; Edwards CA; Crozier A
    J Agric Food Chem; 2010 Jan; 58(2):1296-304. PubMed ID: 20041649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenyl-γ-valerolactones, flavan-3-ol colonic metabolites, protect brown adipocytes from oxidative stress without affecting their differentiation or function.
    Mele L; Carobbio S; Brindani N; Curti C; Rodriguez-Cuenca S; Bidault G; Mena P; Zanotti I; Vacca M; Vidal-Puig A; Del Rio D
    Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28276197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated bioavailability and 48 h excretion profile of flavan-3-ols from green tea in humans.
    Calani L; Del Rio D; Luisa Callegari M; Morelli L; Brighenti F
    Int J Food Sci Nutr; 2012 Aug; 63(5):513-21. PubMed ID: 22133145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of coffee chlorogenic acids and green tea flavan-3-ols.
    Del Rio D; Stalmach A; Calani L; Crozier A
    Nutrients; 2010 Aug; 2(8):820-33. PubMed ID: 22254058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.